Breeze Meds Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 7.4/10
Best for: compounded GLP-1 access with named prescribers and 4-pharmacy network
Breeze Meds stands out for its medical oversight and the pharmacy behind it.
Semaglutide
Tirzepatide
then $399/mo ongoing
What the monthly price covers
Medication
Included
Provider visits
Not disclosed
Shipping
Included
Lab work
Not disclosed
Coaching
Not disclosed
No insurance needed · Vetted by our editors
Breeze Meds is a Georgia-based telehealth provider offering compounded semaglutide ($199/mo), tirzepatide ($399/mo), and NAD+ ($169/mo) across all 50 states. LegitScript certified; named medical team (Dr. Ana Lisa Carr MD, Dr. Kelly Tenbrink MD) and a 4-pharmacy compounding network (Belmar, Strive, Epiq Scripts, Casa Pharma Rx) via Lion MD.
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Vetted alternatives to Breeze Meds
Wellorithm
Best for: compounded GLP-1 access with oral tablet options across 49 states
Editorial score · methodology
Editorial score · methodology
Editorial score · methodology
Breeze Meds at a glance
- Type
- GLP-1 telehealth provider
- Medications
- Semaglutide, Tirzepatide
- Starting price
- $199/mo (Displayed on rendered homepage card 'GLP-1 Injection / Starting at $199'.)
- What's included
- Medication · Shipping
- Availability
- All 50 states
- FDA status
- No FDA warning letter on record
How we scored Breeze Meds
Each dimension is scored algorithmically from Breeze Meds’s real pricing, drugs offered, verification status, and disclosed inclusions — using the same six-dimension framework we apply to every provider.
Value25%
6.7/10At $199/mo, Breeze Meds runs about 18% above the $169 median for GLP-1 providers, and the first month drops to $299.
Effectiveness25%
8.1/10Breeze Meds offers both semaglutide and tirzepatide — the two GLP-1 molecules with the strongest published weight-loss trial outcomes. An oral/needle-free option is offered for patients who avoid injections.
User Experience15%
7.1/10Online intake and platform experience; 6 platform features disclosed.
Trust & Safety15%
8.4/10Core details confirmed by our editors; no FDA warning letters on file; dispenses through an accredited compounding pharmacy; discloses which pharmacy makes its medication.
Accessibility10%
8.2/10Breeze Meds treats patients in all 50 states.
Support10%
5.8/10Breeze Meds provides standard clinician follow-up; no extended coaching or community program is disclosed.
Providers that don’t post pricing up front score lower on Value and carry a cost-transparency note in their review. Read the full methodology →
How we verified this Breeze Meds review
Last checked August 2026- Confirmed current pricing across 4 dose/plan tiers
- Confirmed availability in all 50 states
- Confirmed what the monthly price does and doesn't include
- Verified the compounding pharmacy partner and its accreditation
- Checked the FDA warning-letter database for enforcement actions
- Walked the public intake/checkout flow on the provider's site
Pricing, availability, and compliance facts come from the provider's own site and primary regulatory records — see the sources below. Editorial confidence in this data: medium.
What we checked
- Provider's own pricing page
- $199–$399/mo across 4 dose/plan tiers — checked July 2026
- State pharmacy licensing & LegitScript status
- LegitScript Verified
- FDA warning-letter register
- No letter on file for this provider
- Compounding pharmacy partners
- Belmar Pharmacy, Strive Pharmacy, Epiq Scripts, Casa Pharma Rx
What to expect when you sign up with Breeze Meds
We walked Breeze Meds’s public signup flow in July 2026 to document the process — the steps, pricing transparency, and what’s required — before you commit. (We don’t create accounts, enter medical information, or check out; this is the observable funnel, not a prescribing outcome.)
- 1Start an online consultation/intake via the 'Get Started' flow.
- 2A provider reviews your information and issues a prescription.
- 3Medication ships with expedited delivery; the site states the full process typically takes 2-3 weeks from consultation to receiving medication.
- Homepage shows starting prices before intake (GLP-1 injections 'Starting at $199,' NAD+ 'Starting at $169').
- 'Fast, Free Shipping' and 'Discreet Shipping' are advertised.
- Overall timeline stated as 2-3 weeks from consultation to delivery.
- No refund or cancellation policy was visible on the pages reviewed.
- Support listed as an email address; no phone or hours published.
Breeze Meds customer support
GLP-1 medications Breeze Meds offers
Tap any medication to read our plain-English guide — how it works, dosing, side effects, and what the trials found.
Peptides Breeze Meds offers
Beyond GLP-1s, Breeze Meds also offers these peptides — tap any for our evidence-based guide.
Pricing
Prices re-verified
Displayed on rendered homepage card 'GLP-1 Injection / Starting at $199'.
Homepage card displays 'Starting at $399'.
Rendered card 'Oral Semaglutide / Starting at $299 / One dissolvable tablet per day.' Catalog bundles: 899/3mo, 1799/6mo, 3498/yr.
Rendered card 'Oral Tirzepatide / Starting at $399 / One dissolvable tablet per day.' Catalog bundles: 1199/3mo, 2399/6mo, 4799/yr.
Ready to get started?
Plans and promotions change often — check Breeze Meds's current pricing and active discounts before you decide.
Breeze Meds compounding-pharmacy partners
Each partner below is a 503A or 503B pharmacy that Breeze Meds routes prescriptions through.
What we like
- Available in all 50 states
- LegitScript Certified
- Publicly named medical team: Dr. Ana Lisa Carr, MD and Dr. Kelly Tenbrink, MD
- Four named 503A pharmacy partners: Belmar, Strive, Epiq Scripts, and Casa Pharma Rx
- Semaglutide and tirzepatide offered in both injectable and oral forms
- No FDA warning letters or litigation on record
Watch-outs
- Shares clinicians and pharmacies with Care Bare Rx and Synergy Rx — three storefronts on one operation, not independent providers
- Compounded medications are not FDA-approved
- Compounded vs. brand-name sourcing is unclear on the product pages
- Terms of Service page returns a 404 (only the Privacy Policy is present)
- Insurance acceptance isn't clearly disclosed beyond FSA/HSA eligibility
Breeze Meds: a Georgia compounding storefront with a named medical team
Breeze Meds is a telehealth brand run by Breezemeds, LLC, a Delaware company operating out of Marietta, Georgia. It sells compounded semaglutide, tirzepatide, and NAD+ to patients in all 50 states, and it does two things most cash-pay compounding shops won't: it publishes the actual doctors behind the prescriptions and it lists every pharmacy that fills them. If you want to know exactly who is signing off on your medication and where it's coming from, that transparency is the real reason to look here. The catch — and it's a meaningful one — is that Breeze Meds isn't quite the independent operation it appears to be.
What you actually pay
Pricing is straightforward and runs on a flat monthly model: $199 a month for injectable compounded semaglutide, with tirzepatide priced higher, and oral versions of both also on the menu at their own rates. The medication and shipping are bundled into that number, so there's no surprise pharmacy charge stacked on top. For context, $199 sits a bit above the category median of $169 a month, so Breeze Meds is not the cheapest compounded option out there. You're paying a small premium. The question is whether the named clinicians and disclosed pharmacy network are worth it to you.
Breeze Meds does not appear to run a discounted first-month teaser rate, so the price you start at is roughly the price you keep paying. It advertises free shipping and notes that purchases are FSA/HSA eligible, which can soften the cost if you have a tax-advantaged health account.
The medications and how they're dispensed
Everything Breeze Meds sells is compounded, not brand-name. That's the important distinction to understand before you order: compounded semaglutide and tirzepatide are mixed by a pharmacy rather than manufactured and FDA-approved like Wegovy, Ozempic, or Zepbound. Compounded drugs are legal to prescribe but are not reviewed by the FDA for safety, effectiveness, or quality. Breeze Meds' product pages don't always make the compounded-versus-brand distinction obvious, so go in knowing you're buying a compounded formulation.
The unusual part is the pharmacy side. Rather than relying on a single mystery compounder, Breeze Meds names a four-pharmacy network — Belmar, Strive, Epiq Scripts, and Casa Pharma Rx — coordinated through a clinical group called Lion MD. Offering both injectable and oral forms of each drug gives needle-averse patients a real alternative, which not every compounding provider bothers to do.
The differentiator: it tells you who and where
Most cash-pay compounding sites hide their clinicians and their pharmacy behind a generic 'licensed providers' line. Breeze Meds does the opposite. It publicly names its prescribers — Dr. Ana Lisa Carr, MD and Dr. Kelly Tenbrink, MD — down to their NPI numbers, and it lists all four compounding pharmacies by name. It also displays a LegitScript certification, the screening program that vets online pharmacies and is required to advertise this category on Google. Taken together, that's more checkable detail than the typical competitor offers, and it's the single best argument for choosing Breeze Meds.
The part the marketing doesn't mention: it's one of three storefronts
Here's the most important thing on this page. Breeze Meds shares its exact clinician team and its exact four pharmacies with two other brands — Care Bare Rx and Synergy Rx. Same doctors, same NPI numbers, same compounders. In practice these are three white-labeled storefronts sitting on top of one underlying telehealth-and-compounding operation, not three independent providers competing on quality. If you're price-shopping across all three thinking you're comparing different companies, you're not — you're comparing three front-ends to the same back office. That doesn't make Breeze Meds bad, but it should reset your expectations about what 'shopping around' between them gets you.
Who it's for — and who should skip it
Breeze Meds is a reasonable fit if transparency matters to you and you're comfortable with compounded medication: you can see the doctors, the pharmacies, and the LegitScript seal, and it ships nationwide with no brand-name premium. It's also worth a look if you want an oral option instead of injections.
- Consider it if: you want named, lookup-able prescribers and a disclosed pharmacy network, you're fine with compounded (non-FDA-approved) drugs, or you specifically want an oral GLP-1 alternative.
- Skip it if: you want brand-name Wegovy, Ozempic, Mounjaro, or Zepbound (Breeze Meds doesn't sell them), or you're hunting for the lowest possible price (it runs above the category median). Skip it, too, if you want to comparison-shop genuinely independent providers; Care Bare Rx and Synergy Rx are the same operation.
Trust, safety, and the loose ends
On the positive side, Breeze Meds carries no FDA warning letters and no litigation on record, its medical team and pharmacies can be looked up, and the LegitScript certification is a real screening signal. Those are genuine trust markers in a category full of anonymous sellers.
On the other side, a few things keep this from being a clean bill of health. The Terms of Service page returns a 404 — only a Privacy Policy is live — which is a sloppy gap for a company handling prescriptions and your money. Insurance handling isn't clearly spelled out beyond FSA/HSA eligibility, and the product pages don't consistently clarify the compounded-versus-brand sourcing. And the white-label cluster means the 'independent provider' framing is, at best, incomplete. You can read more about how we weigh these signals in our scoring methodology.
Bottom line
Breeze Meds earns points for doing what most compounding storefronts won't: naming its doctors, listing its pharmacies, and showing a LegitScript seal. That transparency, plus all-50-states access and an oral option, makes it a credible choice at $199 a month if you're comfortable with compounded medication. Just go in with two facts straight: everything here is compounded and not FDA-approved, and Breeze Meds is one of three identical storefronts, not a standalone provider. Confirm the current price, the pharmacy your order ships from, and the refund terms before you commit.
Worth pricing against Eden ($198/month) and HumeCare+ ($199/month) before you commit — both sit close to Breeze Meds on cost and formulation.
The Bottom Line
Breeze Meds stands out for its medical oversight and the pharmacy behind it.
Ready to start with Breeze Meds?
Starting at $199/month. See current pricing and start your free consultation.
Breeze Meds might not be your best fit if…
We rank editorially, so here’s where a different provider we track may serve you better.
- If you want brand-name Ozempic, Wegovy, Mounjaro or Zepbound, consider GobyMeds.
- If the lowest possible monthly price is your top priority, consider Collective (from $59/mo).
- If you want built-in coaching and behavior-change support, consider Fella Health.
Frequently Asked Questions
Key terms, explained
New to GLP-1s? Tap any term for a quick, plain-English definition.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
The primary regulatory filings and peer-reviewed studies cited throughout this Breeze Meds review:
Sources & methodology — as of October 2026
- 1.Weight Loss Rankings — GLP-1 Pricing Index 2026 (our independent dataset)— WeightLossRankings.org.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Garvey WT et al.)— New England Journal of Medicine.PMID: 40334173.
See Breeze Meds's current pricing
Plans start at $199/month. Start your free consultation to check eligibility and today's price.